This is VAERS ID 267474

History of Changes from the VAERS Wayback Machine

First Appeared on 12/30/2006

Vaccin­ation / Manu­facturer	Lot / Dose	Site / Route
HPV4: HUMAN PAPILLOMAVIRUS RECOMBINANT VACCINE, QUADRIVALENT (GARDASIL) / MERCK & CO. INC.	- / 0	- / -

Administered by: Other      Purchased by: Unknown
Symptoms: Dizziness, Dyspnoea, Tension, Throat tightness

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness:
Preexisting Conditions: Adverse event
Allergies:
Diagnostic Lab Data:
CDC 'Split Type':

Write-up: Information has been received from a physician concerning a female age /"14 or 15 years old/" who on an unspecified date was vaccinated with the first dose of 0.5 ml of GARDASIL. After vaccination, the patient felt faint. It was reported that the patient"felt dizzy, had difficulty breathing (also reported as /"had a short of breath feeling/"), felt like her throat was closing and looked tense. Her lungs were clear, there was no wheezing, no signs or symptoms of swelling, no facial or eye swelling and her

---

Changed on 12/8/2009

Vaccin­ation / Manu­facturer	Lot / Dose	Site / Route
HPV4: HUMAN PAPILLOMAVIRUS RECOMBINANT VACCINE, QUADRIVALENT (GARDASIL) HPV (GARDASIL) / MERCK & CO. INC.	- / 0	- / -

Administered by: Other      Purchased by: Unknown Other
Symptoms: Dizziness, Dyspnoea, Tension, Throat tightness

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness:
Preexisting Conditions: Adverse event
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': (blank) WAES0610USA15327

Write-up: Information has been received from a physician concerning a female age /"14 "14 or 15 years old/" old" who on an unspecified date was vaccinated with the first dose of 0.5 ml of GARDASIL. After vaccination, the patient felt faint. It was reported that the patient"felt patient felt dizzy, had difficulty breathing (also reported as /"had "had a short of breath feeling/"), feeling"), felt like her throat was closing and looked tense. Her lungs were clear, there was no wheezing, no signs or symptoms of swelling, no facial or eye swelling and her blood pressure was stable. The physician reported that she thought this looked like a "slight reaction." The patient was given diphenhydramine hydrochloride (BENADRYL) as a precaution. The physician reported that the events were resolving that same day. It was reported that the patient "experienced similar symptoms not relating to vaccines and felt the symptoms may have been more panic driven than anything else." At the time of this report, the patient had recovered from the events (date unknown). The physician reported that she did not feel that the treatment with diphenhydramine hydrochloride (BENADRYL) was needed to prevent serious criteria and did not feel that this experience was life-threatening to the patient. Additional information has been requested.

---

Changed on 3/14/2014

Vaccin­ation / Manu­facturer	Lot / Dose	Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC.	- / 0	- UN / - UN

Administered by: Other      Purchased by: Other
Symptoms: Dizziness, Dyspnoea, Tension, Throat tightness

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness:
Preexisting Conditions: Adverse event
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': WAES0610USA15327

Write-up: Information has been received from a physician concerning a female age "14 or 15 years old" who on an unspecified date was vaccinated with the first dose of 0.5 ml of GARDASIL. After vaccination, the patient felt faint. It was reported that the patient felt dizzy, had difficulty breathing (also reported as "had a short of breath feeling"), felt like her throat was closing and looked tense. Her lungs were clear, there was no wheezing, no signs or symptoms of swelling, no facial or eye swelling and her blood pressure was stable. The physician reported that she thought this looked like a "slight reaction." The patient was given diphenhydramine hydrochloride (BENADRYL) as a precaution. The physician reported that the events were resolving that same day. It was reported that the patient "experienced similar symptoms not relating to vaccines and felt the symptoms may have been more panic driven than anything else." At the time of this report, the patient had recovered from the events (date unknown). The physician reported that she did not feel that the treatment with diphenhydramine hydrochloride (BENADRYL) was needed to prevent serious criteria and did not feel that this experience was life-threatening to the patient. Additional information has been requested.

---

Changed on 6/14/2014

Vaccin­ation / Manu­facturer	Lot / Dose	Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC.	- / 0	UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Dizziness, Dyspnoea, Tension, Throat tightness

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness:
Preexisting Conditions: Adverse event
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': WAES0610USA15327

Write-up: Information has been received from a physician concerning a female age "14 or 15 years old" who on an unspecified date was vaccinated with the first dose of 0.5 ml of GARDASIL. After vaccination, the patient felt faint. It was reported that the patient felt dizzy, had difficulty breathing (also reported as "had a short of breath feeling"), felt like her throat was closing and looked tense. Her lungs were clear, there was no wheezing, no signs or symptoms of swelling, no facial or eye swelling and her blood pressure was stable. The physician reported that she thought this looked like a "slight reaction." The patient was given diphenhydramine hydrochloride (BENADRYL) as a precaution. The physician reported that the events were resolving that same day. It was reported that the patient "experienced similar symptoms not relating to vaccines and felt the symptoms may have been more panic driven than anything else." At the time of this report, the patient had recovered from the events (date unknown). The physician reported that she did not feel that the treatment with diphenhydramine hydrochloride (BENADRYL) was needed to prevent serious criteria and did not feel that this experience was life-threatening to the patient. Additional information has been requested.

---

Changed on 3/14/2015

Vaccin­ation / Manu­facturer	Lot / Dose	Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC.	- / 0	UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Dizziness, Dyspnoea, Tension, Throat tightness

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness:
Preexisting Conditions: Adverse event
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': WAES0610USA15327

Write-up: Information has been received from a physician concerning a female age "14 or 15 years old" who on an unspecified date was vaccinated with the first dose of 0.5 ml of GARDASIL. After vaccination, the patient felt faint. It was reported that the patient felt dizzy, had difficulty breathing (also reported as "had a short of breath feeling"), felt like her throat was closing and looked tense. Her lungs were clear, there was no wheezing, no signs or symptoms of swelling, no facial or eye swelling and her blood pressure was stable. The physician reported that she thought this looked like a "slight reaction." The patient was given diphenhydramine hydrochloride (BENADRYL) as a precaution. The physician reported that the events were resolving that same day. It was reported that the patient "experienced similar symptoms not relating to vaccines and felt the symptoms may have been more panic driven than anything else." At the time of this report, the patient had recovered from the events (date unknown). The physician reported that she did not feel that the treatment with diphenhydramine hydrochloride (BENADRYL) was needed to prevent serious criteria and did not feel that this experience was life-threatening to the patient. Additional information has been requested.

---

Changed on 9/14/2017

Vaccin­ation / Manu­facturer	Lot / Dose	Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC.	- / 0 1	UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Dizziness, Dyspnoea, Tension, Throat tightness

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness:
Preexisting Conditions: Adverse event
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': WAES0610USA15327

Write-up: Information has been received from a physician concerning a female age "14 or 15 years old" who on an unspecified date was vaccinated with the first dose of 0.5 ml of GARDASIL. After vaccination, the patient felt faint. It was reported that the patient felt dizzy, had difficulty breathing (also reported as "had a short of breath feeling"), felt like her throat was closing and looked tense. Her lungs were clear, there was no wheezing, no signs or symptoms of swelling, no facial or eye swelling and her blood pressure was stable. The physician reported that she thought this looked like a "slight reaction." The patient was given diphenhydramine hydrochloride (BENADRYL) as a precaution. The physician reported that the events were resolving that same day. It was reported that the patient "experienced similar symptoms not relating to vaccines and felt the symptoms may have been more panic driven than anything else." At the time of this report, the patient had recovered from the events (date unknown). The physician reported that she did not feel that the treatment with diphenhydramine hydrochloride (BENADRYL) was needed to prevent serious criteria and did not feel that this experience was life-threatening to the patient. Additional information has been requested.

---

Changed on 2/14/2018

Vaccin­ation / Manu­facturer	Lot / Dose	Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC.	- / 1	UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Dizziness, Dyspnoea, Tension, Throat tightness

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness:
Preexisting Conditions: Adverse event
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': WAES0610USA15327

Write-up: Information has been received from a physician concerning a female age "14 or 15 years old" who on an unspecified date was vaccinated with the first dose of 0.5 ml of GARDASIL. After vaccination, the patient felt faint. It was reported that the patient felt dizzy, had difficulty breathing (also reported as "had a short of breath feeling"), felt like her throat was closing and looked tense. Her lungs were clear, there was no wheezing, no signs or symptoms of swelling, no facial or eye swelling and her blood pressure was stable. The physician reported that she thought this looked like a "slight reaction." The patient was given diphenhydramine hydrochloride (BENADRYL) as a precaution. The physician reported that the events were resolving that same day. It was reported that the patient "experienced similar symptoms not relating to vaccines and felt the symptoms may have been more panic driven than anything else." At the time of this report, the patient had recovered from the events (date unknown). The physician reported that she did not feel that the treatment with diphenhydramine hydrochloride (BENADRYL) was needed to prevent serious criteria and did not feel that this experience was life-threatening to the patient. Additional information has been requested.

---

Changed on 6/14/2018

Vaccin­ation / Manu­facturer	Lot / Dose	Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC.	- / 1	UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Dizziness, Dyspnoea, Tension, Throat tightness

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness:
Preexisting Conditions: Adverse event
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': WAES0610USA15327

Write-up: Information has been received from a physician concerning a female age "14 or 15 years old" who on an unspecified date was vaccinated with the first dose of 0.5 ml of GARDASIL. After vaccination, the patient felt faint. It was reported that the patient felt dizzy, had difficulty breathing (also reported as "had a short of breath feeling"), felt like her throat was closing and looked tense. Her lungs were clear, there was no wheezing, no signs or symptoms of swelling, no facial or eye swelling and her blood pressure was stable. The physician reported that she thought this looked like a "slight reaction." The patient was given diphenhydramine hydrochloride (BENADRYL) as a precaution. The physician reported that the events were resolving that same day. It was reported that the patient "experienced similar symptoms not relating to vaccines and felt the symptoms may have been more panic driven than anything else." At the time of this report, the patient had recovered from the events (date unknown). The physician reported that she did not feel that the treatment with diphenhydramine hydrochloride (BENADRYL) was needed to prevent serious criteria and did not feel that this experience was life-threatening to the patient. Additional information has been requested.

---

Changed on 8/14/2018

Vaccin­ation / Manu­facturer	Lot / Dose	Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC.	- / 1	UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Dizziness, Dyspnoea, Tension, Throat tightness

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness:
Preexisting Conditions: Adverse event
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': WAES0610USA15327

Write-up: Information has been received from a physician concerning a female age "14 or 15 years old" who on an unspecified date was vaccinated with the first dose of 0.5 ml of GARDASIL. After vaccination, the patient felt faint. It was reported that the patient felt dizzy, had difficulty breathing (also reported as "had a short of breath feeling"), felt like her throat was closing and looked tense. Her lungs were clear, there was no wheezing, no signs or symptoms of swelling, no facial or eye swelling and her blood pressure was stable. The physician reported that she thought this looked like a "slight reaction." The patient was given diphenhydramine hydrochloride (BENADRYL) as a precaution. The physician reported that the events were resolving that same day. It was reported that the patient "experienced similar symptoms not relating to vaccines and felt the symptoms may have been more panic driven than anything else." At the time of this report, the patient had recovered from the events (date unknown). The physician reported that she did not feel that the treatment with diphenhydramine hydrochloride (BENADRYL) was needed to prevent serious criteria and did not feel that this experience was life-threatening to the patient. Additional information has been requested.

New Search